NuVasive reported its consolidated net income in the third quarter of $7.3 million, up nearly 250 percent compared to the same period last year. The company reported $169 million in total third quarter revenue, up 14 percent from the same period last year. Spine revenue also jumped this past quarter, up 16 percent to $131 million. Biologics and monitoring services experienced modest increases.
More Articles on Devices:
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
Baxano Surgical Granted Patent for Visual Approach of Lateral Access Fusion System
Orthozon Technologies' Lumiere Retractor System Recognized as Top Device for Spine